Utama › Kanser Hati (Karsinoma Hepatoselular)
Kajian klinikal Kanser Hati (Karsinoma Hepatoselular) sedang mengambil peserta di AS
131 kajian untuk Kanser Hati (Karsinoma Hepatoselular) sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX31 kajian
- New York City, NY24 kajian
- Dallas, TX19 kajian
- Los Angeles, CA19 kajian
- Boston, MA18 kajian
- Cleveland, OH18 kajian
- Chicago, IL16 kajian
- Philadelphia, PA16 kajian
- Pittsburgh, PA15 kajian
- San Francisco, CA14 kajian
- Orange, CA14 kajian
- Jacksonville, FL14 kajian
- San Antonio, TX13 kajian
- St. Louis, MO13 kajian
- Rochester, MN12 kajian
- Detroit, MI11 kajian
- Portland, OR11 kajian
- Baltimore, MD11 kajian
- Atlanta, GA11 kajian
- Seattle, WA10 kajian
- Nashville, TN10 kajian
- Mountain View, CA10 kajian
- Washington, DC10 kajian
- Arlington, VA9 kajian
- Baldwin Park, CA9 kajian
- Ann Arbor, MI9 kajian
- Birmingham, AL8 kajian
- Durham, NC8 kajian
- Milwaukee, WI8 kajian
- Santa Monica, CA8 kajian
- San Diego, CA8 kajian
- Scottsdale, AZ7 kajian
- Phoenix, AZ7 kajian
- Omaha, NE7 kajian
- Miami, FL7 kajian
- Tampa, FL7 kajian
- Irvine, CA6 kajian
- New Haven, CT6 kajian
- Tucson, AZ6 kajian
- Aurora, CO6 kajian
Mengikut negeri
- Alabama9 kajian
- Arizona17 kajian
- California54 kajian
- Colorado11 kajian
- Connecticut8 kajian
- Delaware3 kajian
- Florida27 kajian
- Georgia12 kajian
- Hawaii3 kajian
- Illinois20 kajian
- Indiana5 kajian
- Iowa3 kajian
- Kentucky6 kajian
- Louisiana5 kajian
- Maryland16 kajian
- Massachusetts19 kajian
- Michigan20 kajian
- Minnesota21 kajian
- Missouri14 kajian
- Nebraska8 kajian
- Nevada4 kajian
- New Hampshire3 kajian
- New Jersey10 kajian
- New York33 kajian
- North Carolina11 kajian
- Ohio23 kajian
- Oklahoma5 kajian
- Oregon11 kajian
- Pennsylvania27 kajian
- Rhode Island3 kajian
- South Carolina6 kajian
- Tennessee14 kajian
- Texas50 kajian
- Utah5 kajian
- Virginia17 kajian
- Washington15 kajian
- Wilayah Columbia4 kajian
- Wisconsin12 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 45 hingga 75 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06995898A Study of ZW251 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07164313Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT03942328Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06265285A Phase 1 Study of the Safety and Tolerability of CTX-10726
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07419841Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06726161Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07227012National Liver Cancer Screening Trial
Mengambil pesertaFasa 4
Umur 18 hingga 85 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06084234A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07291076Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06915753Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Mengambil pesertaFasa 2
Umur 18 hingga 100 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07219459A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06066138GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Mengambil pesertaFasa awal 1
Umur 18 hingga 99 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07627191A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Mengambil peserta
Umur 21 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07824583A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06427941Defining the Ablative Dose for Y-90 TARE
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07586046A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06007846Evaluating Novel Therapies in ctDNA Positive GI Cancers
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05482516Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04380545Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Mengambil pesertaKajian pemerhatian
Umur 22 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06486454GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT04864054Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06526338Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06811116Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.